NEWS

Press Releases

Media Coverage

Additional Partnerships

04/01/2026

Tempus and Medtronic Announce ALERT Trial Results Showing AI-Driven EHR Notifications Improve Treatment for Significant Valvular Heart Disease

ALERT is the largest known multicenter, cluster-randomized trial to date evaluating an automated EHR-based notification system designed to address the undertreatment of significant valvular heart disease and accelerate time to treatment. Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced results f...
03/19/2025

HumanX
Eric Lefkofsky shares how Tempus is building and deploying hundreds of agents designed to deliver insights to physicians and researchers.
03/13/2025

Fox Business
Tempus Founder and CEO Eric Lefkofsky discusses bringing AI to diagnostics on ‘The Claman Countdown’
02/17/2025

CNBC
Tempus Founder and CEO, Eric Lefkofsky, discusses how generative AI is more impactful in healthcare diagnostics
01/03/2025

2024 Forbes Healthcare Summit
Tempus Founder and CEO, Eric Lefkofsky, discusses "Bringing The Power Of Data And AI To Healthcare"
07/16/2024

Tempus and Softbank Group
Press Conference: Announcement of “SB Tempus"
06/14/2024

CNBC
Tempus AI founder and CEO Eric Lefkofsky joins 'Squawk Box' to discuss taking the company public on Nasdaq.
04/21/2023

Forbes
Key Lessons Entrepreneurs Must Know | Eric Lefkofsky
12/13/2022

Milken Institute’s Future of Health
Tempus Founder and CEO, Eric Lefkofsky, joins the panel "Building the Clinical Trial Enterprise of the Future"
06/14/2022
- AI
- Data
Fast Company
We need health data banks not unlike what we have for organ donors

1 2 3